Hyaluronan and collagen in human hypertrophic cardiomyopathy: a morphological analysis

Martin Hellström1, Anna Engström-Laurent, Stellan Mörner

  • 1Department of Public Health and Clinical Medicine, Medicine, Umeå University, 90187 Umeå, Sweden.

Insights

Hyaluronan (HA) is more abundant in hypertrophic cardiomyopathy (HCM) hearts, but its receptor CD44 is not detected. HA and collagen I share similar locations in HCM myocardial tissue.

Area of Science:

  • Cardiovascular Pathology
  • Extracellular Matrix Biology

Background:

  • Hypertrophic cardiomyopathy (HCM) involves cardiomyocyte and extracellular matrix (ECM) abnormalities.
  • Hyaluronan (HA) and its receptor CD44 are implicated in cell growth and proliferation.
  • The role of HA and its distribution in HCM, particularly in relation to collagen, is not well understood.

Purpose of the Study:

  • To investigate the histological distribution of hyaluronan (HA) in human hypertrophic cardiomyopathy (HCM).
  • To examine the presence of the HA receptor, CD44, in HCM myocardium.
  • To compare the localization of HA and collagen I in HCM.

Main Methods:

  • Myocardial tissue samples were obtained from 5 patients undergoing myectomy for symptomatic HCM.
  • Histochemistry and immunohistochemistry techniques were employed to analyze tissue composition.
  • Staining for HA, CD44, and Collagen I was performed on patient and control samples.

Main Results:

  • Hyaluronan (HA) staining intensity was significantly higher in HCM patients compared to controls.
  • HA was distributed interstitially, within fibrous septa, and in the adventitia of intramyocardial vessels in both groups.
  • CD44 receptor was not detected in the myocardium of either HCM patients or controls.
  • Collagen I exhibited a similar overall localization to HA, but with distinct detailed distribution patterns.

Conclusions:

  • This study provides the first description of hyaluronan distribution in human HCM.
  • Increased HA staining in HCM is not associated with CD44 receptor coexpression in the chronic phase.
  • Hyaluronan and Collagen I share common localization patterns within the hypertrophic cardiomyopathy myocardium.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...